Initial Director's Interest Notice

Aug 31, 2026 at 3:24 AM EDT · Issued by Percheron Therapeutics Limited via ASX

Filed with ASX · Aug 31, 2026 at 3:24 AM EDT

On 6ix: 6ix.com/news/initial-directors-interest-notice-89

Appendix 3X Initial Director’s Interest Notice + See chapter 19 for defined terms. 11/3/2002 Appendix 3X Page 1 Rule 3.19A.1 Appendix 3X Initial Director’s Interest Notice Information or documents not available now must be given to ASX as soon as available. ...

View Attachment

6ix hasn’t read this filing yet.

Percheron Therapeutics Limited on 6ix

Earlier from Percheron Therapeutics

Transitional appointment of Executive DirectorAug 31
Change of Director's Interest NoticeAug 31
Notification of cessation of securities - PERAug 31
Percheron receives $0.70m R&D Tax Incentive RebateAug 30
Trading HaltAug 27

Later from Percheron Therapeutics

Proposed issue of securities - PERAug 31
Percheron raises $2.3m to fully fund clinical trial in AMLAug 31
Percheron Therapeutics Limited Corporate PresentationAug 31
2026 Notice of Annual General MeetingSep 6
Application for quotation of securities - PERSep 6

All Percheron Therapeutics news releases

Follow Percheron Therapeutics into a list and get an email when it puts out news.

Follow Percheron Therapeutics